… and enterococcal isolates from infections in patients housed in … Pseudomonas aeruginosa
and Acinetobacter baumannii have developed resistance to multiple antimicrobial agents …

… , Acinetobacter baumannii, Pseudomonas aeruginosa, and … baumannii infections, there is
mounting pressure to find new … While A.baumannii remains a major public health challenge …

… but not in Enterobacteriaceae or in Pseudomonas aeruginosa (… baumannii has been identified
and characterized as a … these agents in the treatment of serious Acinetobacter infections …

… to antimicrobial drugs currently used for the treatment of … baumannii; however, Spanish
researchers have identified … Considering the issues presented previously, we will further discuss …

… baumannii treatment and the principal issues involved. … The most important finding of the
present study is that ampicillin–… combination with another active antimicrobial agent. Many MDR …

… baumannii, with the objective of identifying the most … that effectively escape the effects
of antibacterial drugs [16]. … such as Pseudomonas aeruginosa, Acinetobacter baumannii, …

… a challenge to the healthcare system due to their resilience against antimicrobial agents
and … , mechanisms involved in biofilm formation and/or biofilm antimicrobial tolerance in P. …

… baumannii and Pseudomonas aeruginosa. Evidence is … challenging therapeutic quandaries
when treating patients … Finally, the development of new, more potent antibacterial drugs …

… to multiple antibiotics and at the origin of severe infections is … Among the increasingly reported
and commonly identified … Acinetobacter baumannii and Pseudomonas aeruginosa occupy …

… of Pseudomonas aeruginosa isolates to these same antibiotics … entirely new targets for
antibacterial drugs could be identified, … cost of developing a new antibacterial agent is not justified …